These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6438554)

  • 21. Nonrandom chromosomal changes in transitional cell carcinoma of the bladder.
    Vanni R; Scarpa RM
    Cancer Res; 1986 Sep; 46(9):4873. PubMed ID: 3731134
    [No Abstract]   [Full Text] [Related]  

  • 22. Chromosomal analysis as prognostic tool in transitional cell carcinoma: preliminary report.
    Gonick P; Kalathoor R; Fuscaldo K
    Urology; 1980 Nov; 16(5):527-9. PubMed ID: 7445296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chromosome markers and progression in bladder cancer.
    Sandberg AA
    Cancer Res; 1977 Aug; 37(8 Pt 2):2950-6. PubMed ID: 872125
    [No Abstract]   [Full Text] [Related]  

  • 24. [Molecular cytogenetic study of bladder transitional cell carcinoma by FISH].
    Shou J; Wang M; Ma J
    Zhonghua Zhong Liu Za Zhi; 2000 Jan; 22(1):36-8. PubMed ID: 11776593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytogenetic analysis of transitional cell carcinoma of the bladder. Clinical implications.
    Martorana G; Giberti C; de Ferrari M; Calvi P; Ottaggio L; Pescatore D
    Eur Urol; 1983; 9(1):28-31. PubMed ID: 6822239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistomorphologic and molecular cytogenetic analysis of a carcinosarcoma of the urinary bladder.
    Gronau S; Menz CK; Melzner I; Hautmann R; Möller P; Barth TF
    Virchows Arch; 2002 Apr; 440(4):436-40. PubMed ID: 11956826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cytogenetic analysis of transitional cell carcinoma of the bladder, stage B (pT2-3a/pN0)].
    Angulo JC; López JI; Sanchez-Chapado M
    Actas Urol Esp; 1994 Jun; 18(6):651-5. PubMed ID: 7942216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Karyotype and FISH analysis of a newly established cell line derived from a human bladder carcinoma.
    Perissel B; Benkhalifa M; Taillandier J; Dastugue N; Haus O; Charbonné F; Giraud B; Malet P
    Cancer Genet Cytogenet; 1993 Jun; 67(2):101-7. PubMed ID: 8330265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of cytogenetic subgroups and karyotypic pathways in transitional cell carcinoma.
    Höglund M; Säll T; Heim S; Mitelman F; Mandahl N; Fadl-Elmula I
    Cancer Res; 2001 Nov; 61(22):8241-6. PubMed ID: 11719456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA flow cytometric analysis and numerical chromosome 9 aberrations detected by interphase cytogenetics in superficial bladder TCC.
    Eleuteri P; Grollino MG; Pomponi D; Calugi G; Rocchi M; De Vita R
    Eur J Histochem; 1997; 41 Suppl 2():161-2. PubMed ID: 9859830
    [No Abstract]   [Full Text] [Related]  

  • 31. Grading in superficial bladder cancer. (2). Cytogenetic classification.
    Pauwels RP; Smeets AW; Schapers RF; Geraedts JP; Debruyne FM
    Br J Urol; 1988 Feb; 61(2):135-9. PubMed ID: 3349278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identical genetic profiles in primary and metastatic bladder tumors.
    Summers JL; Falor WH; Ward RM; Fiorito J; Brezler MR; Abreu AJ
    J Urol; 1983 Apr; 129(4):827-8. PubMed ID: 6573516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interphase cytogenetic studies of bladder cancer.
    Wang MR; Perissel B; Taillandier J; Malet P
    Bull Cancer; 1994 Dec; 81(12):1060-6. PubMed ID: 7742594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural chromosome 1 aberrations in transitional cell carcinoma of the bladder: interphase cytogenetics combining a centromeric, telomeric, and library DNA probe.
    Poddighe PJ; Ramaekers FC; Smeets AW; Vooijs GP; Hopman AH
    Cancer Res; 1992 Sep; 52(18):4929-34. PubMed ID: 1516049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular analysis of human bladder cancer.
    Olumi AF; Skinner EC; Tsai YC; Jones PA
    Semin Urol; 1990 Nov; 8(4):270-7. PubMed ID: 1980959
    [No Abstract]   [Full Text] [Related]  

  • 36. Characterization of chromosomal abnormalities in uroepithelial carcinomas by G-banding, spectral karyotyping and FISH analysis.
    Fadl-Elmula I; Kytölä S; Pan Y; Lui WO; Derienzo G; Forsberg L; Mandahl N; Gorunova L; Bergerheim US; Heim S; Larsson C
    Int J Cancer; 2001 Jun; 92(6):824-31. PubMed ID: 11351302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Study on significance of multitargeted fluorescence in situ hybridization for urothelial carcinoma].
    Xiao L; Yin YL; Zhu XZ; Chen Y; Lu C; Yu B
    Zhonghua Bing Li Xue Za Zhi; 2013 Jul; 42(7):465-6. PubMed ID: 24246866
    [No Abstract]   [Full Text] [Related]  

  • 38. [Prognostic factors and markers used in urothelial carcinoma of the bladder].
    Billerey C; Vieillefond A
    Ann Pathol; 1999; 19(5 Suppl):S107-9. PubMed ID: 10599469
    [No Abstract]   [Full Text] [Related]  

  • 39. Cytogenetic heterogeneity in a second primary radiation-induced bladder carcinoma: ten karyotypically unrelated clones.
    Fadl-Elmula I; Bonaldi L; Gorunova L; Mandahl N; Elfving P; Heim S
    Cancer Genet Cytogenet; 1998 Sep; 105(2):134-7. PubMed ID: 9723030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic aberrations of the K-ras proto-oncogene in bladder cancer in Kashmiri population.
    Nanda MS; Sameer AS; Syeed N; Shah ZA; Murtaza I; Siddiqi MA; Ali A
    Urol J; 2010; 7(3):168-73. PubMed ID: 20845292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.